Douleur Neuropathique 4 Questionnaire

Bouhassira, Didier; Attal, Nadine; Alchaar, H.; Boureau, F.; Brochet, Bruno; Bruxelle, J.; Cunin, G.; Fermanian, Jacques; Giniès, P.; Grun-Overdyking, Aurélie; Jafari-Schluep, Hélène; Lantéri-Minet, Michel; Beaugerie, Laurent; Mick, G.; Serrié, Alain; Valade, Dominique; Vicaut, Éric

doi:10.1037/t31094-000

Cited by 10 publications

(25 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The French version [7,21] demonstrated very low-level evidence for satisfactory criterion validity and low level evidence for satisfactory hypothesis testing (part of construct validity) and reliability (table 2). Content validity and structural validity (another aspect of construct validity) was unsatisfactory with very low level and low level of evidence respectively.…”

Section: Dn4mentioning

confidence: 94%

“…The DN4 was originally developed in French in France [7]. The French version [7,21] demonstrated very low-level evidence for satisfactory criterion validity and low level evidence for satisfactory hypothesis testing (part of construct validity) and reliability (table 2).…”

Section: Dn4mentioning

confidence: 99%

“…A C C E P T E D ACCEPTED MANUSCRIPT 4 The Neuropathic Pain Special Interest Group (NeuPSIG) of the International Association for the Study of Pain (IASP) has recommended five questionnaires to screen for neuropathic pain [5]; these are the Douleur Neuropathique 4 (DN4) [7], ID Pain [8], the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) [9], the PainDETECT questionnaire [10] and the Neuropathic Pain Questionnaire [11]. These questionnaires have been developed [7][8][9][10][11], modified [e.g.12] and culturally adapted to other languages [e.g.13] and used in various neuropathic pain disorders, with individual studies testing their measurement properties.…”

Section: A N U S C R I P Tmentioning

confidence: 99%

“…Most studies administered the questionnaires face to face in a clinical setting, most commonly by a pain physician or specialist [7][8][9][10]12,[29][30][31][32]34,35,37,40,42,43,45,48] …”

Section: Study Characteristicsmentioning

confidence: 99%

“…These questionnaires have been developed [7][8][9][10][11], modified [e.g.12] and culturally adapted to other languages [e.g.13] and used in various neuropathic pain disorders, with individual studies testing their measurement properties. Critically appraising the measurement properties of these questionnaires may guide clinicians and researchers on the relevance and clinical value of these questionnaires.…”

Section: A N U S C R I P Tmentioning

confidence: 99%

See 4 more Smart Citations

Neuropathic pain screening questionnaires have limited measurement properties. A systematic review

Mathieson

Maher

Terwee

et al. 2015

Journal of Clinical Epidemiology

111

View full text Add to dashboard Cite

Section: Dn4mentioning

confidence: 94%

Section: Dn4mentioning

confidence: 99%

Section: A N U S C R I P Tmentioning

confidence: 99%

“…Most studies administered the questionnaires face to face in a clinical setting, most commonly by a pain physician or specialist [7][8][9][10]12,[29][30][31][32]34,35,37,40,42,43,45,48] …”

Section: Study Characteristicsmentioning

confidence: 99%

Section: A N U S C R I P Tmentioning

confidence: 99%

See 3 more Smart Citations

Neuropathic pain screening questionnaires have limited measurement properties. A systematic review

Mathieson

Maher

Terwee

et al. 2015

Journal of Clinical Epidemiology

111

View full text Add to dashboard Cite

Assessment of diabetic small‐fiber neuropathy by using short‐wave infrared hyperspectral imaging

Sheen

Sheu

Wang

et al. 2021

Journal of Biophotonics

View full text Add to dashboard Cite

Among patients with type 2 diabetes mellitus (T2DM), the association between hyperspectral imaging (HSI) examination and diabetic neuropathy (DN) is ascertained using HSI of the feet using four types of spectral difference measurements. DN was evaluated by traditional Michigan Neuropathy Screening Instrument (MNSI), evaluation of painful neuropathy (ID-Pain, DN4) and sudomotor function by measuring electrochemical skin conductance (ESC). Of the 120 T2DM patients and 20 healthy adults enrolled, T2DM patients are categorized into normal sudomotor (ESC >60 μS)and sudomotor dysfunction (ESC ≤ 60 μS) groups. Spectral difference analyses reveal significant intergroup differences, whereas traditional examinations cannot distinguish between the two groups. HSI waveform reflectance gradually increases with disease severity, at 1400 to 1600 nm. The area under the curve (AUC) of receiver operating characteristic (ROC) analysis for abnormal ESC is ≥0.8 for all four HSI methods. HSI could be an objective, sensitive, rapid, noninvasive and remote approach to identify early small-fiber DN.diabetic neuropathy (DN), electrochemical skin conductance (ESC), hyperspectral imaging (HSI), short-wave infrared (SWIR), type 2 diabetes mellitus (T2DM)

show abstract

Prevalence and factors associated with persistent pain following body contouring surgery

Chatel

Madar

Leyder

et al. 2016

Journal of Plastic, Reconstructive & Aesthetic Surgery

View full text Add to dashboard Cite

show abstract

Douleur Neuropathique 4 Questionnaire

Cited by 10 publications

References 0 publications

Neuropathic pain screening questionnaires have limited measurement properties. A systematic review

Neuropathic pain screening questionnaires have limited measurement properties. A systematic review

Assessment of diabetic small‐fiber neuropathy by using short‐wave infrared hyperspectral imaging

Prevalence and factors associated with persistent pain following body contouring surgery

Contact Info

Product

Resources

About